ALBUQUERQUE, N.M., April, 10, 2015 – Stuart Rose, the CEO and founder of PaizaBio, LLC, a contract manufacturing company in the pharmaceutical company, has named Lux + Associates as its agency of record. Lux will create all branding, advertising and public for the company, which will officially launch in October 2015 at the CPhI Global Trade Show in Madrid.

PaizaBio is targeting Western pharmaceutical companies that want to expand into China’s sterile injectable drug market and take advantage of the country’s 1.4 billion strong population. As China has become more affluent, the demand for Western pharmaceuticals has also grown. Yet drug companies face a time-consuming and difficult task if they choose to build a manufacturing plant in China. PaizaBio has been manufacturing sterile injectable drugs in China for two decades via a strategic partner in Hangzhou. PaizaBio will enable Western drug companies the opportunity to rapidly enter the Chinese market without capital outlay, minimal risk and with complete confidence in PaizaBio’s manufacturing quality.

Lux has already completed the company’s graphic identity and website, which very clearly reflects PaizaBio’s focus on China. The firm is now concentrating its efforts on creating awareness and conversation using traditional public relations, social media and a major launch in pharmaceutical publications.